Regeneron Pharmaceuticals, Inc.

Ownership Transactions Reported by 23 Insiders

Symbol
REGN on Nasdaq
Location
777 Old Saw Mill River Road, Tarrytown, NY

Insiders trading volume in the past year

Regeneron Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
George Yancopoulos Bd. Co-Chair, President & CSO, Director $1.13B -$128M -10.2% Jun 10, 2024
Leonard S. Schleifer Bd. Co-Chair, President & CEO, Director $687M -$84M -10.9% Jun 11, 2024
Vagelos P Roy Director $444M Apr 3, 2023
Neil Stahl EVP Research and Development $65.2M -$13.3M -16.9% Aug 13, 2024
Andrew Murphy EVP Research $61M -$23.4M -27.7% Aug 13, 2024
Joseph Larosa EVP General Counsel and Secret $41.7M -$6.8M -14% Jul 11, 2024
George L. Sing Director $33.5M -$5.33M -13.7% Sep 4, 2024
Daniel P. Van Plew EVP & General Mgr, Industrial $32.2M -$9.83M -23.4% Feb 14, 2024
Robert E. Landry EVP Finance CFO $22.9M Feb 2, 2024
Christopher R. Fenimore SVP Finance & CFO $22.6M -$15.3M -40.3% Aug 28, 2024
Arthur F. Ryan Director $18.6M -$1.17M -5.92% Oct 1, 2024
Marion McCourt EVP Commercial $13.8M -$9M -39.4% Oct 1, 2024
Michael S. Brown Director $13M -$4.58M -26% Jun 14, 2024
Joseph L. Goldstein Director $6.07M -$2.57M -29.8% Jan 23, 2024
Jason Pitofsky VP Controller $4.51M -$521K -10.4% Aug 7, 2024
Christine A. Poon Director $2.52M -$12.6M -83.3% Aug 15, 2024
Marc Tessier-Lavigne Director $2.32M Jan 3, 2023
Bonnie L. Bassler Director $1.62M -$6.28M -79.5% Aug 15, 2024
N. Anthony Coles Director $1.33M Jan 2, 2024
Huda Y. Zoghbi Director $1.31M -$1.01M -43.3% Jan 2, 2024
Craig B. Thompson Director $432K Jan 2, 2024
Kathryn Guarini Director $268K Jan 2, 2024
David Schenkein Director $268K Jan 2, 2024

Recent Insider Transactions by Companies or Individuals for Regeneron Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.